Grupo Cibest S.A. CIB ← Back to all reports

Grupo Cibest S.A.

CIB · Financials
B ★★★ Hold
Jul 25, 2026 · Score 81 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $84.66
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $78.00 ($75.00–$81.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $94.30
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+11.4%

Type A - Grupo Cibest S.A. (CIB) 20260725 Stock Analysis

📅 Grupo Cibest Key Upcoming Events

🏢 Step 1: Grupo Cibest Company Overview & Business Model

Q1-A1. What is Grupo Cibest?

Q1-A2. How Does Grupo Cibest Make Money?

Q1-A3. Grupo Cibest’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Grupo Cibest’s Competitors?

Q1-A5. Grupo Cibest Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Grupo Cibest’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Grupo Cibest Have a Durable Economic Moat?

Q2-A2. Is Grupo Cibest’s Growth Sustainable?

Q2-A3. How Does Grupo Cibest Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Grupo Cibest Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Grupo Cibest? (Margins & ROIC)

Q3-A3. What Drives Grupo Cibest’s Returns? (ROIC Breakdown)

Q3-A4. Are Grupo Cibest’s Earnings High Quality?

Q3-A5. Is Grupo Cibest’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Grupo Cibest Forensic Accounting & Dilution Review

Q4-A1. Does Grupo Cibest Have Accounting Red Flags?

Q4-A2. Is Grupo Cibest Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Grupo Cibest’s Cash Flow?

Q4-A4. Is Grupo Cibest Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Grupo Cibest Management & Shareholder Alignment

Q5-A1. Can You Trust Grupo Cibest’s Management? (Guidance Track Record)

Q5-A2. What Are Grupo Cibest Insiders Doing?

Q5-A3. Is Grupo Cibest’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Grupo Cibest Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Grupo Cibest Guidance

Q6-A2. What Is Grupo Cibest’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Grupo Cibest Catalysts & Price Triggers

Q7-A1. What Could Move Grupo Cibest Stock? (Top 3 Catalysts)

Q7-A2. Grupo Cibest’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Grupo Cibest Fairly Valued? Valuation Analysis

Q8-A1. Grupo Cibest’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Grupo Cibest vs Peers: Valuation Comparison

Q8-A3. Is Grupo Cibest Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Grupo Cibest? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. Grupo Cibest’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Grupo Cibest? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Grupo Cibest?

Q9-A2. How Sensitive Is Grupo Cibest to the Economy?

Q9-A3. Grupo Cibest Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Grupo Cibest Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Grupo Cibest? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Grupo Cibest’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Grupo Cibest’s Exposure to Colombia’s Fiscal Policy and Wealth Tax Its Biggest Weakness?

Q2: Can Grupo Cibest’s 11.3x P/E Be Justified by the Divestment of Banistmo and the Hyper-Growth of Nequi?

Q3: How Will the $1.4 Billion Proceeds from the Banistmo Sale Reshape Grupo Cibest’s Capital Allocation?

Q4: Are the Accelerating Growth Metrics of Nequi and Wompi Enough to Offset Traditional Banking Margin Compression?

Q5: Is the Recent Spike in the 90-Day NPL Ratio to 2.51% a Temporary Blip or a Structural Deterioration?

Q6: Can Grupo Cibest Maintain Its Massive 6.58% Dividend Yield Amidst Regulatory Headwinds?

Q7: Will the COP 1.35 Trillion Share Buyback Program Trigger a Sustained Re-rating of the ADRs?

Q8: Does the Evolution into a Holding Company Structure Genuinely Unlock Shareholder Value for Grupo Cibest?

Q9: Is Grupo Cibest Losing Ground to Neo-Banks and Fintech Startups in the Colombian Market?

Q10: How Vulnerable Is Grupo Cibest’s Central American Portfolio (Banco Agrícola and BAM) to U.S. Macro Shocks?

Grupo Cibest S.A. (CIB)